User:RelentlessRecusant/BPIQ-II

BPIQ-II, IUPAC name 8-[(3-Bromophenyl)amino]-1H-imidazo[4,5-γ]-quinazoline, is a small molecule chemical inhibitor of the epidermal growth factor receptor (EGFR). It was discovered in 1996 by Rewcastle et. al at the University of Auckland School of Medicine in New Zealand and Parke-Davis Pharmaceutical Research in Michigan.